BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29415975)

  • 21. Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.
    Pagano L; Valentini CG; Grammatico S; Pulsoni A
    Br J Haematol; 2016 Jul; 174(2):188-202. PubMed ID: 27264021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells.
    Boiocchi L; Lonardi S; Vermi W; Fisogni S; Facchetti F
    Blood; 2013 Jul; 122(2):296-7. PubMed ID: 23847189
    [No Abstract]   [Full Text] [Related]  

  • 23. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
    Patel JL; Shetty S; Salama ME
    Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.
    Jaye DL; Geigerman CM; Herling M; Eastburn K; Waller EK; Jones D
    Mod Pathol; 2006 Dec; 19(12):1555-62. PubMed ID: 16998465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blastic plasmacytoid dendritic cell neoplasm: report of two pediatric cases.
    Dharmani PA; Mittal NM; Subramanian PG; Galani K; Badrinath Y; Amare P; Gujral S
    Indian J Pathol Microbiol; 2015; 58(1):72-6. PubMed ID: 25673598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow : Summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016.
    Tzankov A; Hebeda K; Kremer M; Leguit R; Orazi A; van der Walt J; Gianelli U
    Ann Hematol; 2017 May; 96(5):765-777. PubMed ID: 28191591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of blastic plasmacytoid dendritic cell neoplasm with ecchymotic lesions on the whole body.
    Cui XB; Jin J; Pang XL; Li S; Liu CX; Li TT; Peng H; Zhang SM; Li L; Liang WH; Chen YZ; Li F
    Int J Clin Exp Pathol; 2014; 7(7):4391-9. PubMed ID: 25120824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Sukswai N; Aung PP; Yin CC; Li S; Wang W; Wang SA; Ortega V; Lyapichev K; Nagarajan P; Alfattal R; Angelova E; Tang Z; Loghavi S; Kanagal-Shamanna R; Miranda RN; Pemmaraju N; Bhalla K; Konopleva M; Medeiros LJ; Khoury JD
    Am J Surg Pathol; 2019 Oct; 43(10):1429-1437. PubMed ID: 31261288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Blastic plasmacytoid dendritic cell neoplasm: A clinico-pathological retrospective analysis of thirteen cases].
    Nong L; Wang W; Liang L; Li D; Li X; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):308-314. PubMed ID: 37042142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmacytoid dendritic cell neoplasms.
    Lee YJ; Kim Y; Park SH; Jo JC
    Blood Res; 2023 Apr; 58(S1):90-95. PubMed ID: 37105563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic Cell Leukemia: a Review.
    Tsagarakis NJ; Paterakis G
    Curr Oncol Rep; 2020 May; 22(6):55. PubMed ID: 32415624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The differentiation of new human CD303
    Zhong Q; Lu Y; Xu W; Rong Z; Chang X; Qin L; Chen X; Zhou F
    Int Immunopharmacol; 2021 Oct; 99():107983. PubMed ID: 34298400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
    Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry.
    Pennisi M; Cesana C; Cittone MG; Bandiera L; Scarpati B; Mancini V; Soriani S; Veronese S; Truini M; Rossini S; Cairoli R
    Case Rep Hematol; 2017; 2017():4984951. PubMed ID: 28409040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.
    Zhang YW; Zhong JH; Chen XL; Xiao F; Chen FY
    Exp Ther Med; 2016 Jul; 12(1):319-322. PubMed ID: 27347056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A CD56- immunoblastoid variant of blastic plasmacytoid dendritic cell neoplasm.
    Aran BM; Duran J; Whittemore D; Gru AA
    J Cutan Pathol; 2024 Jan; 51(1):40-44. PubMed ID: 37612885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Khoury JD
    Curr Hematol Malig Rep; 2018 Dec; 13(6):477-483. PubMed ID: 30350260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review.
    Wang Y; Xiao L; Yin L; Zhou L; Deng Y; Deng H
    Medicine (Baltimore); 2023 Feb; 102(7):e32904. PubMed ID: 36800625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm.
    Cronin DM; George TI; Reichard KK; Sundram UN
    Am J Clin Pathol; 2012 Mar; 137(3):367-76. PubMed ID: 22338048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.